PhRMA Statement on the 340B Drug Pricing Program
November 13, 2024
November 13, 2024
WASHINGTON, Nov. 13 -- The Pharmaceutical Research and Manufacturers of America issued the following statement on Nov. 12, 2024:
* * *
Today, Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Alex Schriver released the following statement on the 340B drug pricing program:
"We continue to have serious concerns about persistent and often illegal abuse of 340B, which is driving up costs for patients, employers and taxpayer . . .
* * *
Today, Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Alex Schriver released the following statement on the 340B drug pricing program:
"We continue to have serious concerns about persistent and often illegal abuse of 340B, which is driving up costs for patients, employers and taxpayer . . .